|
98
|
272
|
5dvcA |
Human ppargamma ligand binding dmain complexed with sb1453 in a covalent bonded form |
|
94
|
244
|
5duhA |
Crystal structure of the er-alpha ligand-binding domain in complex with a sulfoxide-bridged oxabicyclic heptene sulfonate (sobhs)-3 analog phenyl (1s,2s,4s,7s)-5,6-bis(4-hydroxy-3-methylphenyl)-7-thiabicyclo[2.2.1]hept-5-ene-2-sulfonate 7-oxide |
|
94
|
244
|
5drmA |
Crystal structure of the er-alpha ligand-binding domain in complex with a dichloro-substituted, 2,5-diarylthiophene-core ligand 4,4'-thiene-2,5-diylbis(3-chlorophenol) |
|
87
|
245
|
5dz0A |
Crystal structure of the er-alpha ligand-binding domain in complex with the cyclofenil derivative 4,4'-[(4-methylcyclohexylidene)methanediyl]diphenol |
|
88
|
241
|
5dx3B |
Estrogen receptor alpha ligand binding domain y537s mutant in complex with stapled peptide src2-p3 and estradiol |
|
92
|
272
|
5dshA |
Human ppargamma ligand binding dmain complexed with sb1406 in a covalent bonded form |
|
81
|
243
|
5dxqA |
Crystal structure of the er-alpha ligand-binding domain in complex with the cyclofenil derivative 4,4'-[(1s,5s)-bicyclo[3.3.1]non-9-ylidenemethanediyl]diphenol |
|
89
|
241
|
5dx3A |
Estrogen receptor alpha ligand binding domain y537s mutant in complex with stapled peptide src2-p3 and estradiol |
|
85
|
244
|
5dwiA |
Crystal structure of the er-alpha ligand-binding domain in complex with a resorcinyl 2-chloro-substituted diaryl-imine analog 4-[(e)-[(2-chlorophenyl)imino](4-hydroxyphenyl)methyl]benzene-1,3-diol |
|
97
|
272
|
5dv3A |
Human ppargamma ligand binding dmain complexed with sb1405 in a covalent bonded form |
|
84
|
244
|
5dxmA |
Crystal structure of the er-alpha ligand-binding domain in complex with the cyclofenil derivative 3-[(e)-(1s,5s)-bicyclo[3.3.1]non-9-ylidene(4-hydroxyphenyl)methyl]phenol |
|
93
|
272
|
5dv8A |
Human ppargamma ligand binding dmain complexed with sb1451 in a covalent bonded form |
|
86
|
245
|
5dxrA |
Crystal structure of the er-alpha ligand-binding domain in complex with the cyclofenil derivative 4,4'-{[(3r)-3-methylcyclohexylidene]methanediyl}diphenol |
|
83
|
246
|
5dz1A |
Crystal structure of the er-alpha ligand-binding domain in complex with the cyclofenil derivative 4,4'-[(4-ethylcyclohexylidene)methanediyl]diphenol |
|
85
|
243
|
5dxpA |
Crystal structure of the er-alpha ligand-binding domain in complex with the cyclofenil derivative 4-[(e)-(1s,5s)-bicyclo[3.3.1]non-9-ylidene(phenyl)methyl]phenol |
|
90
|
242
|
5dxbB |
Estrogen receptor alpha ligand binding domain y537s mutant in complex with stapled peptide src2-p1 and estradiol |
|
94
|
272
|
5dv6A |
Human ppargamma ligand binding dmain complexed with sb1404 in a covalent bonded form |
|
89
|
243
|
5dugA |
Crystal structure of the er-alpha ligand-binding domain in complex with a sulfoxide-bridged oxabicyclic heptene sulfonate (sobhs)-2 analog phenyl (1s,2s,4s,7s)-5,6-bis(4-hydroxy-2-methylphenyl)-7-thiabicyclo[2.2.1]hept-5-ene-2-sulfonate 7-oxide |
|
87
|
244
|
5dtvA |
Crystal structure of the er-alpha ligand-binding domain in complex with a dimethyl-substituted, 3,4-diarylthiophene dioxide core ligand |
|
88
|
244
|
5dxkA |
Crystal structure of the er-alpha ligand-binding domain in complex with the cyclofenil derivative 4,4'-[(9s)-bicyclo[3.3.1]non-9-ylmethanediyl]diphenol |
|
83
|
242
|
5dvsA |
Crystal structure of the er-alpha ligand-binding domain in complex with a 2-methyl-substituted triaryl-imine 4,4'-[(2-methylphenyl)carbonimidoyl]diphenol |
|
80
|
244
|
5dwgA |
Crystal structure of the er-alpha ligand-binding domain in complex with the triaryl-substituted imine analog, 4-{(e)-(4-hydroxyphenyl)[(2-methylphenyl)imino]methyl}benzene-1,3-diol |
|
101
|
273
|
5dwlA |
Human ppargamma ligand binding dmain in complex with sr1664 |
|
86
|
243
|
5dmcA |
Crystal structure of the er-alpha ligand-binding domain in complex with a nitrile-substituted triaryl-ethylene derivative 3,3-bis(4-hydroxyphenyl)-2-phenylprop-2-enenitrile |
|
95
|
244
|
5di7A |
Crystal structure of the er-alpha ligand-binding domain in complex with an methyl-substituted a-cd ring estrogen derivative (1s,3ar,5s,7as)-5-(4-hydroxy-2-methylphenyl)-7a-methyloctahydro-1h-inden-1-ol |
|
91
|
245
|
5dlrA |
Crystal structure of the er-alpha ligand-binding domain in complex with a triaryl-ethylene compound 4,4'-(2-phenylethene-1,1-diyl)diphenol |
|
89
|
244
|
5dkbA |
Crystal structure of the er-alpha ligand-binding domain in complex with a 3-methylphenylamino-substituted ethyl triaryl-ethylene derivative 4,4'-(2-{3-[(3-methylphenyl)amino]phenyl}but-1-ene-1,1-diyl)diphenol |
|
86
|
244
|
5dmfA |
Crystal structure of the er-alpha ligand-binding domain in complex with a 4-fluorophenylamino-substituted, methyl triaryl-ethylene derivative 4,4'-(2-{3-[(4-fluorophenyl)amino]phenyl}prop-1-ene-1,1-diyl)diphenol |
|
84
|
250
|
5ak2A |
Oxyphenylpropenoic acids as oral selective estrogen receptor down- regulators. |
|
85
|
244
|
5dkeA |
Crystal structure of the er-alpha ligand-binding domain in complex with a 3-naphthyl-substituted, methyl, cis-diaryl-ethylene compound 4,4'-[2-(naphthalen-2-yl)prop-1-ene-1,1-diyl]diphenol |
|
89
|
247
|
5dl4A |
Crystal structure of the er-alpha ligand-binding domain in complex with a phenylamino-substituted, methyl, triaryl-ethylene derivative 4,4'-{2-[3-(phenylamino)phenyl]prop-1-ene-1,1-diyl}diphenol |
|
91
|
248
|
5digA |
Crystal structure of the er-alpha ligand-binding domain in complex with a trifluoromethyl-substituted a-cd ring estrogen derivative (1s,3ar,5s,7as)-5-[4-hydroxy-2-(trifluoromethyl)phenyl]-7a-methyloctahydro-1h-inden-1-ol |
|
89
|
243
|
5dk9A |
Crystal structure of the er-alpha ligand-binding domain in complex with a phenylamino-substituted ethyl triaryl-ethylene derivative 4,4'-{2-[3-(phenylamino)phenyl]but-1-ene-1,1-diyl}diphenol |
|
95
|
246
|
5didA |
Crystal structure of the er-alpha ligand-binding domain in complex with a difluoro-substituted a-cd ring estrogen derivative (1s,3ar,5s,7as)-5-(2,3-difluoro-4-hydroxyphenyl)-7a-methyloctahydro-1h-inden-1-ol |
|
87
|
245
|
5dkgA |
Crystal structure of the er-alpha ligand-binding domain in complex with a t-butyl-substituted, methyl, triaryl-ethylene derivative 4,4'-[2-(4-tert-butylphenyl)prop-1-ene-1,1-diyl]diphenol |
|
75
|
244
|
5dksA |
Crystal structure of the er-alpha ligand-binding domain in complex with a 2-naphthylamino-substituted, ethyl, triaryl-ethylene derivative 4,4'-{2-[3-(naphthalen-1-ylamino)phenyl]but-1-ene-1,1-diyl}diphenol |
|
88
|
244
|
5dieA |
Crystal structure of the er-alpha ligand-binding domain in complex with a trifluoro-substituted a-cd ring estrogen derivative (1s,3ar,5s,7as)-7a-methyl-5-(2,3,5-trifluoro-4-hydroxyphenyl)octahydro-1h-inden-1-ol |
|
83
|
244
|
5dp0A |
Crystal structure of the er-alpha ligand-binding domain in complex with a 4-fluorophenylamino-substituted triaryl-ethylene derivative 4,4'-(2-{3-[(4-fluorophenyl)amino]phenyl}ethene-1,1-diyl)diphenol |
|
85
|
252
|
4zo1X |
Crystal structure of the t3-bound tr-beta ligand-binding domain in complex with rxr-alpha |
|
93
|
252
|
4ynkA |
Crystal structure of vitamin d receptor ligand binding domain complexed with a 19-norvitamin d compound |
|
87
|
249
|
4znvA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with a 2-methoxy-substituted obhs derivative |
|
63
|
225
|
4zo1B |
Crystal structure of the t3-bound tr-beta ligand-binding domain in complex with rxr-alpha |
|
82
|
223
|
4zomA |
Rorgamma in complex with inverse agonist 4j. |
|
100
|
248
|
5cj6A |
Crystal structure of a selective androgen receptor modulator bound to the ligand binding domain of the human androgen receptor |
|
90
|
246
|
4znhA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with a 2-fluoro-substituted obhs derivative |
|
81
|
243
|
4znuA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with a 2-methyl-substituted obhs derivative |
|
90
|
246
|
4znsA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with a 3-fluoro-substituted obhs derivative |
|
83
|
246
|
4znwA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with a 4-bromo-substituted obhs derivative |
|
99
|
271
|
4xumA |
Ppargamma ligand binding domain in complex with indomethacin |
|
87
|
266
|
4xtaA |
Mechanisms of ppargamma activation by non-steroidal anti-inflammatory drugs |
